// company-profile
Arrowhead Pharmaceuticals, Inc.
ARWR// activity-summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Cohen Matthew Gregory.
// 90-day insight
Over the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders bought $0 across 1 transaction with no open-market sales.
- Most active insider: Apel Daniel Joseph with 3 transactions totaling $934K.
- Largest single sale: $750K by Hamilton James C on Apr 23, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Arrowhead Pharmaceuticals, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Cohen Matthew Gregory | ARWR | Award | 11,882 | $0.00 | $0K |
| May 12, 2026 | Lu Hongbo | ARWR | Sale10b5 | 2,970 | $76.88 | $228K |
| Apr 23, 2026 | Hamilton James C | ARWR | Sale10b5 | 10,000 | $75.00 | $750K |
| Apr 22, 2026 | Apel Daniel Joseph | ARWR | Sale10b5 | 3,208 | $70.11 | $225K |
| Apr 22, 2026 | Apel Daniel Joseph | ARWR | Sale10b5 | 8,730 | $71.92 | $628K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.